Kythera Biopharmaceuticals is a privately held biopharmaceutical company focused on science and innovation in aesthetic medicine.

This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.

Kythera has active or exploratory programs in adipolysis, dermal contouring, pigmentation modulation, photoaging, and topical neuromodulation.